| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2011/03/08 | 04 : 58 | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 25 to Delist & Deregister Contingent Value Rights for APP Pharmaceuti... | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2011/02/23 | 20 : 04 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2011/02/23 | 20 : 04 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2011/02/23 | 15 : 01 | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 10-K for APP Pharmaceuticals, Inc. (APP) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2011/01/26 | 22 : 00 | Business Wire | APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/11/30 | 15 : 01 | Business Wire | APP Pharmaceuticals Announces Approval and Launch of Topotecan for Injection | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/11/06 | 04 : 39 | Business Wire | APP Pharmaceuticals to Launch Drug Hotline | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/11/02 | 19 : 04 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/11/02 | 09 : 16 | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/10/30 | 07 : 53 | Business Wire | APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/08/03 | 08 : 15 | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/08/03 | 06 : 16 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/07/28 | 02 : 14 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/07/06 | 14 : 01 | Business Wire | APP Pharmaceuticals Announces Marketing Clearance of Preservative-Free Heparin Lock Flush Solution, USP | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/06/30 | 03 : 44 | Edgar (US Regulatory) | Annual Report of Employee Stock Plans (11-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/06/29 | 14 : 01 | Business Wire | APP Pharmaceuticals to Market Anastrozole Tablets in the U.S. | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/06/22 | 14 : 01 | Business Wire | APP Pharmaceuticals Announces Approval of Ganciclovir for Injection, USP | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/06/21 | 14 : 01 | Business Wire | APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/06/11 | 14 : 01 | Business Wire | APP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S. | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/06/08 | 14 : 01 | Business Wire | APP Pharmaceuticals Receives Approval for Lyophilized Oxaliplatin for Injection | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/05/10 | 19 : 07 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/05/04 | 19 : 04 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/05/04 | 07 : 41 | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/04/02 | 00 : 39 | Business Wire | Fresenius Kabi Enters Into Licensing and Settlement Agreements with sanofi-aventis | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/04/01 | 06 : 27 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/03/25 | 22 : 15 | GlobeNewswire Inc. | Emerging Stock Report Initiates Independent Research Coverage on Fresenius Kabi Pharmaceuticals Holding, Inc. | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/03/23 | 14 : 01 | Business Wire | APP Pharmaceuticals Receives Approval for Indomethacin for Injection | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/02/26 | 05 : 43 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/02/24 | 20 : 03 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 2010/02/24 | 10 : 08 | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-K | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |